Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Revelation Biosciences Inc increased its cash reserves by 128.28%, or 6.74m. Cash Flow from Financing totalled 14.03m or -- of revenues. In addition the company used 7.29m for operations while cash used for investing totalled .
Cash flow per share | -20.07 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6939 |
---|---|
Tangible book value per share | 0.6939 |
More ▼
Balance sheet in USDView more
Current ratio | 1.10 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼